Boston Partners’s Usana Health Sciences USNA Stock Holding History

Boston Partners’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,226	Closed	-$1.45M	–	746
2019 Q3	$1.45M	Sell	21,226 -250	-1%	-$16.8K	﹤0.01%	551
2019 Q2	$1.71M	Buy	+21,476	New	+$1.7M	﹤0.01%	556

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Boston Partners's USNA Position: Q4 2019 in Review

Boston Partners sold out of Usana Health Sciences (USNA) in Q4 2019, closing a stake of 21,226 shares — an estimated $1.45M sold.

Boston Partners first reported a position in USNA in Q2 2019 and held it in 2 quarters. The position peaked at $1.71M in Q2 2019. 175 funds tracked by Wall St. Rank hold USNA as of Q4 2019.

Boston Partners reported no remaining Usana Health Sciences position as of Q4 2019 after selling out during the quarter.
Boston Partners sold 21,226 Usana Health Sciences shares in Q4 2019, an estimated $1.45M.
Boston Partners first reported a position in Usana Health Sciences in Q2 2019 and held it in 2 quarters.
Boston Partners's Usana Health Sciences position peaked at $1.71M in Q2 2019.
175 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2019.

Based on Boston Partners's 13F filing for Q4 2019, filed 5 Feb 2020.